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Summary: Nesidioblastosis pancreas was used as an immunogen in BALB/c-mice to generate monoclonal
antibodies against structures of human islet cells. Seven clones were selected by screening 311 growing
hybridomas for reactivity with the rat insulinoma cell line, RIN m5F, and with cryostat sections from human
pancreas. None of the selected clones reacted with pancreatic hormones or endocrine-specific peptides.
Monoclonal antibodies cross-reacting with the RIN-cell line also bound to different endocrine organs or cell
lines, while some RIN-cell-negative clones bound only to Langerhans islets from human pancreas.
Introduction
The different endocrine cells of human pancreatic
islets of Langerhans serve highly spezialized functions,
such as specific hormone production and secretion.
Furthermore, specific structural elements also seem
to be expressed, at least on the surface of insulin
secreting B^cells. In conjunction with HLA class II
antigens these differentiation antigens might serve as
specific targets for a T-cell response during the au-
toimmune pathögenesis of type I diabetes. Due to the
limited availability of the respective target cell, i. e.
the human B-cell, on the one hand and of the natural
aütoantibodies on the other hand, research on the
immunopathogenesis of type I diabetes is rendered
difficult and therefore little is known about the nature
of the respective cell surface antigens. One way to
approach this problem is the use of monoclonal an-
tibodies directed against defined antigenic sites of the
islet cells. Here we describe the development of a
panel of murine monoclonal antibodies against hu-
man islets of Langerhans derived from nesidioblastosis
tissue. Their cross-reactivity with other endocrine tis-
sues or cells is characterized, and some preliminary
data on the biochemical nature of the respective an-
tigens are presented.
Materials and Methods
Preparation of the immunogen
Nesidioblastosis tissue was obtained after total pancreatectomy
of a one year old female child suffering from severe hypogly-
caemic attacks. Indirect immunofluprescence using islet cell
antibody^positive diabetic sera and an anti-insulin serum from
guinea pig revealed an increased number of intact encapsulated
islets as well as dispersed single islet cells. The fraction used as
an immunogen in mice was prepared in two different ways. In
the first procedure, tissue (100 mg) was homogenized (Potter
homogenizer) in ice cold phosphate buffered saline, and the
homogenate centrifuged at 100 000 g; the pellet fraction was
resuspended in phosphate buffered saline and used as immu-
nogen. It was stored at — 80 °C before use. In parallel, the
nesidioblastosis tissue was subjected to collagenase treatment
according to 1. c. (1). Isolated islets were picked up under a
stereomicroscope and transferred to tissue culture (24 well Cos-
tar plates) in RPMI 1640 medium containing 20% foetal calf
serum. During two weeks in primary culture the intact encap-
suled islets disrupted and formed a monolayer of C-peplide-
and proinsulin-secreting epitheloid like cells. After 4 weeks in
culture the cells were harvested, lysed by freezing and thawing
and centrifuged at 20000g for 20 minutes in the cold. The
supernatant containing the soluble cytoplasmic material was
discarded, and the pellet fraction used as immunogen.
Generation of monoclonal antibodies
BALB/c mice (4—6 weeks old) were immunized either with the
pellet fraction from homogenized nesidioblastosis tissue or by
the membrane fraction from cultured cells. About 10 mg of
protein was injected intraperitoneally four times every three
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weeks. Four days after the last injection the animals were
sacrificed and the spleen cells were harvested and washed three
times in cell culture medium containing L-glutamine, sodium
pyruvate, and penicillin/streptomycin but no foetal calf serum.
Spleen cells (2.2 χ ΙΟ7) were fused with the nonsecretor murine
myeloma cell line NSO (3.5 χ ΙΟ8 cells) (2) using polyethylene
glycol according to the original procedure (3) with slight mod-
ifications. Hypoxanthine, aminopterine, thymidin (HAT) selec-
tion medium was added two days after initial culture in 24 well
Costar plates (2.5 χ ΙΟ5 cells/ml RPMI 1640 containing 20%
foetal calf serum). Five days later surviving cells could be
identified for the first time under the microscope. At this time
the medium was changed twice every week or whenever nec-
essary. Two weeks after fusion, the foetal calf serum content
was reduced from 20 to 10%. Growing hybridomas were dou-
bled and the cell culture supernatant was tested for the presence
of interesting antibodies. Hybridomas producing antibodies
which reacted with islets were cloned by plating 3000 — 300000
cells per ml in 0.3% soft agar containing 20% foetal calf serum
and picking up with glass capillaries 10 days later.
Electron microscopy
For electron microscopy cultured cells were harvested and fixed
in glutaraldehyde (6.25%), postfixed in 2% buffered osmic acid
solution for 2 hours, and embedded in Epon. Semithin sections
were stained in Azur-II-Methylene blue solution (4). Ultrathin
sections were contrasted with uranyl acetate and lead citrate.
Screening for antibody production of the hybridoma
Antibody production of the hybrids was screened by an ELISA
using the rat insulinoma cell line (RINm5F) (5) as well as by
indirect immunofluorescence on cryostat sections from human
pancreas of a blood group 0 donor. Briefly, the procedure of
the ELISA was as follows: about 100 RINm5F cells per well
seeded in microplate wells formed a monolayer after two to
three days in culture. After careful washing with phosphate
buffered saline the cells were fixed by incubation with 0.5%
glutaraldehyde for 15 minutes at room temperature, again
washed three times with phosphate buffered saline, then incu-
bated in phosphate buffered saline containing 150 mmol/1 gly-
cine for 15 minutes. After a further wash the cells were stored
in the cold and could be used within the next four to five days.
Before testing the cell culture supernatants, fixed cells were
washed three times with phosphate buffered saline containing
0.05% Tween 20. Cell culture supernatant (0.1 ml) was then
added and incubated for at least one hour at room temperature.
After washing three times with phosphate buffered saline-
Tween, 0.1 ml of peroxidase-conjugated antimouse immuno-
globulin (Sigma) in a dilution of 1:1000 were added and in-
cubated for one hour. After extensive washing with phosphate
buffered saline-Tween the enzymic reaction was initiated by
addition of 0.1 ml of 5.5 mmol o-phenylene diamine in 100
mmol/1 citrate buffer, pH 5.0. Absorbance was measured in a
Dynatech Microplate Reader MR 600 at 405 nm after a fixed
time of 30 minutes. Absorbance values for controls (medium)
were found between 0.01 and 0.02, while the values for positive,
i.e. antibody-containing cell supernatants ranged from 0.05 —
1.5.
In parallel, hybrids were screened for reactivity with human
islets using an indirect immunofluorescence assay with FITC-
conjugated antimouse immunoglobulin (Sigma) diluted 1:30 in
phosphate buffered saline on cryostat sections of human pan-
creas from a blood group 0 donor. For identification of Lan-
gerhans islets as well as for direct comparison with the clones
to be tested, the following islet cell positive "probes" were used:
1. a mouse monoclonal antibody BISL-32 (6) generated against
bovine islets, but cross-reacting with human islets. This anti-
body was directly labelled with tetramethyl rhodamine isothio-
cyanate and used in a double fluorescence procedure by com-
bining the direct immunofluorescence with tetramethyl rhoda-
mine isothiocyanate labelled BISL-32 with the indirect proce-
dure using the clone to be tested and the FITOlabelled anti-
mouse immunoglobulin as second antibody.
2. an islet cell antibody positive diabetic serum in an indirect
double fluorescence procedure using tetramethyl rhpdamine
isothiocyanate labelled antihuman IgG as well as FITC labelled
antimouse immunoglobulin as second antibodies, respectively
3. a polyclonal antiserum developed against human insulin in
guinea pig in an indirect double fluorescence procedure, using
a tetramethyl rhodamine isothiocyanate-conj gated anti guinea
pig immunoglobulin and FITC-conjugated antimouse iinmu-
noglobulin as the second antibodies, respectively.
Binding assays
Possible reactivity of the selected monoclonal antibodies with
some islet cell-specific polypeptides, such as human proinsulin,
insulin, C-peptide, gl cagon and somatostatin was investigated
in the following way: trace amounts of the respective 125I-
iodinated islet cell-specific polypeptides (about 104 counts/min
χ 0.2 ml) were incubated with the monoclonal antibody to be
tested for 18 hours at 4°C. Following incubation, 0.05 ml of
human γ-globulin and immediately thereafter a solution of 0.25
ml polyethylene glycol (PEG-6000) (25%) was added to achieve
complete precipitation of the antibodies. Samples were centri-
fuged, the pellets were washed twice with polyethylene glycol
solution, then counted for radioactivity. Binding was expressed
as percentage of total radioactivity added.
Western immunoblott ing technique
Nesidioblastosis pancreas (case 3) was first homogenized and
solubilized in 1 % NP40 buffer. After high speed centrifugation
(20000 g) the detergent extracts were resolved in 1% sodium
dodecylsulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) on a gradient gel from 6—16%. Proteins were blotted
onto nitrocellulose paper using a semidry blot apparatus (Bio-
metra, G ttingen) at a constant current of 5 mA/cm2 for 30
minutes. After incubation for 60 minutes with the monoclonal
antibody to be tested (diluted tenfold) the corresponding pro-
tein antigen bands were identified by indirect immunostaining
using biotinylated antimouse immunoglobulin and streptavidin
biotinylated alkaline phosphatase complex (Amershani) with 5-
bromo-4-chloro-3-indolylphosphate as substrate and nitroblue
tetrazoiium salt.
Results
Figure 1 shows the formation of a monolayer of
epitheloid like cells from an isolated nesidioblastosis
islet after 10 days in primary culture. During this time
C-peptide secretion into the culture medium increased
slowly but continuously (data not shown). After four
weeks in culture the cells were harvested by removing
Ca*+ from the medium using 2 mmol/1 EDTA in
phosphate buffered saline. Electron microscopy re-
vealed mostly endocrine cells with typical dense gran-
ula as demonstrated in figure 2. About 50% were B-
cells, 40% Α-cells and the rest could not be identified
exactly.
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Tab. 1. Reactivity of hybridoma supernatants within different
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Fig. 1. Human islet isolated from nesidioblastosis pancreas
after 14 days in culture; formation of a monolayer.
Magnification: χ 100
Fusion of murine spleen cells immunized by islet cell
membrane fractions with the murine myeloma cell
line NSO resulted in 311 growing hybridomas from
a total of 1296 microtitre wells. The screening of the
hybrids for antibody production was first performed
using the RIN-cell ELISA. However, some hybrids,
reactive in the RIN-ELISA, did not react on cryostat
sections from human pancreas, and conversely some
reacting on cryostat sections were negative in the
RIN-ELISA. Thus it was also necessary to test all the
hybrids for reactivity oil cryostat sections from human
pancreas. Table 1 shows the results obtained with
both methods. 24 hybridoma secreted antibodies were
reacting only in the RIN-cell ELISA, 34 hybrids re-
acted in both assay systems, while 42 hybrids were
positive only on pancreatic cryostat sections. From
the latter two groups 1 clones were selected by com-
parison with the fluorescence pattern of islet cell an-
tibody-positive diabetic sera, a polyclonal anti-insulin
serum from guinea pig and the mouse monoclonal
antibovine islet antibody BISL-32.
The islet cell antibody-positive diabetic sera used for
comparison did not react with certain defined cells
within the islets but gave a diffuse staining of the
All
hybrids
311
Reactive with
RIN-ELISA
positive
Cryostate
section negative
24
Cryostat sec-
tion positive
RIN-ELISA
negative
42
positive in
both systems
34
whole islets. The same is true for the monoclonal
antibody BISL-32. However, cell staining with this
antibody was more clear and more related to certain
cell types of the islets. Staining of B-cells was possible
with the polyclonal anti-insulin serum from guinea
pig. Examples for comparison with islet cell-specific
probes are given in the figures 3 a—e and 4 a—e. Some
monoclonal antibodies, for example M AB 1163 Bl,
stained similar structures of the islet architecture as
did the MAB BISL-32 (fig. 3 a and 4 a). Preincubation
of the cryostat sections with excess amounts of puri-
fied monoclonal antibodies followed by incubation
with BISL-32, however, showed that binding of BISL-
32 was unaffected by any of the monoclonals used
for preincubation. Thus, certain monoclonal antibod-
ies demonstrated a similar fluorescence pattern to that
Fig. 2. Electron micrograph of islet cells maintained in culture
for four weeks. A, Α-cells; B, B-cells (magnification:
χ 5000)
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of BISL-32, but none of them reacted with the same
epitopes as did BISL-32. Antibodies 521F2, 673D2
and 673D5 stained structures, which were identified
as B-cells by the use of an antihuman-insulin serum
from guinea pig (fig. 3 b and 4 b). When serial sections
from the same pancreas were incubated with different
monoclonal antibodies, it became evident that differ-
ent substructures or cells were reactive as demon-
strated for MA 794A2 and 866A6 in figure 3 c and
4c.
By use of radioimmunological (RIA) and enzyme-
immunological (ELISA) methods the clones were
tested for reactivity with defined human polypeptides
and structural proteins (tab. 2). None of the mono-
clonal antibodies was able to bind proinsulin, insulin,
C-peptide, glucagon or somatostatin. Binding was
also negative with thyroglobulin and the endocrine-
specific isoenzyme γ-enolase. Monoclonal antibodies
673D2 and D5, 866A6 and 1163B1 gave a low signal
within the heparan sulphate ELISA, while all other
proteins listed in table 2 were negative.
Cross-reactivity of the selected seven monoclonal an-
tibodies on various tissues and cell lines is listed in
table 3. All of our monoclonal antibodies were reac-
tive on islets from normal human pancreas as well as
on cryostat sections from three different nesidioblas-
tosis pancreata, except antibody 1163B1 which was
unreactive on the second nesidioblastosis tissue.
No reaction was observed on sections from human
thyroid, liver, skeletal muscle or two breast cancer
specimens. Monoclonal antibodies 303F1 and 866A6
(fig. 3 e) were reactive on porcine and bovine pancreas,
673D2, D5 and 794A2 only on bovine pancreas. Reac-
tivity within the RIN-cell ELISA of the clones 303F1,
673D2, D5 and 866A6 was also reflected in the in-
direct immunofluorescence with adherent and floating
RIN-cells. Monoclonal antibody 303F1 gave rim flu-
orescence on normal pancreas sections (fig. 3d) as
well as on floating RIN-cells (fig. 4d). Obviously,
reactivity on RIN cells was accompanied by reactivity
on cryostat sections from a solid neuroblastoma as
well as by membrane staining of adherent neuroblas-
toma cells (line SK-N-SH). All other cell lines tested
and listed in table 3 were negative, except the epider-
moid carcinoma cell line A431, which was strongly
stained by monoclonal antibody 1163B1 (fig. 4e).
Western blot experiments were carried out with nesi-
dioblastosis tissue 3. Monoclonal antibodies 673D5
(not shown), 303F1, 521F2 and some hybrids gave
no detectable bands. Small bands were found for
Fig. 3 a-e.
a) Immunofluorescence on human nesidioblastosis pancreas (case 3)
double fluorescence procedure with MA 1163B1 and FITC-labelled
antimouse immunoglobulin (indirect immunofluorescence) χ 170
b) Immunofluorescence on human nesidioblastosis pancreas (case 2)
double fluorescence procedure with MA 673D5 and TRITC-labelled
antimouse immunoglobulin (indirect immunofluorescence) χ 170
c) Serial sections (3c; 4c) from normal human pancreas
MAB 794A2; FITC labelled antimouse immunoglobulin (indirect immunofluorescence)
χ 170
d) Immunofluorescence on normal human pancreas
MAB 303F1; FITC-labelled antimouse immunoglobulin (indirect immunofluorescence)
x420
e) Immunofluorescence on bovine pancreas
MAB 866A6; FITCMabeUed antimouse immunoglobulin (indirect immunofluorescence)
χ 170
Fig. 4 a—e.
a) Same cryostat section as in 3 a
TRITC-labelled MAB BISL-32 (direct immunofluorescence) χ 170
b) same cryostat section as in 3 b
FITC-labelled anti-insulin serum from guinea pig (indirect immunofluorescence)
χ 170
c) Serial section (3c; 4c) from normal human pancreas
MAB 866A6; FITC-labelled antimouse immunoglobulin (indirect immunofluorescence)
χ 170
d) Immunofluorescence on floating RIN m5F cells
MAB 303F1; FITC-labelled antimouse immunoglobulin (indirect immunofluorescence)
x580
e) Immunofluorescence on floating A431 cells
MAB 1163B1; FITC-labelled antimouse immunoglobulin (indirect immunofluorescence)
x720
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Tab. 2. Reactivity of monoclonal islet cell antibodies with defined polypejptides
Polypeptide
Human insulin
proinsulin
C-peptide
glucagon
somatostatin
Thyroglobulin
γ-Enolase
Heparan sulphate
Laminin
Fibronectin
Actin
Human serum albumin
Bovine serum albumin
Insulin receptor
(placenta)
Assay
type
RIA
RIA
RIA
RIA
RIA
RIA
RIA
ELISA
ELISA
ELISA
ELISA
ELISA
ELISA
Western
blot
Clones
303F1 521F2 673D2 673D5 794A2 866A6 1163B1
_ _ _ _ _ — — —
_ _ _ - -~ -
— n.d. n.d. — — — —
n.d. n.d. — — n.d. — —
— — — — — — —
— — — — ^ -τ- —
— — — — — rrr —_
n. d. = not determined
Tab. 3. Reactivity of monoclonal islet cell antibodies with various tissues and cell types
Species of Tissue/cell type
origin
Immunohistochemistry
clones
303F1 521F2 673D2 673D5 794A2 866A6 1163B1
Human Normal pancreas
Nesidioblastosis 1
Nesidioblastosis 2
Nesidioblastosis 3
Thyroid
Liver
Muscle
Breast cancer 1
Breast cancer 2
Neuroblastoma
. Glucagonoma
Bovine pancreas
Porcine pancreas
4-
n.d. n.d.
-f
H-
n. d. n. d.
Cell line
Rat insulinoma RIN m5F
ELISA
viable adherent cells
viable floating cells
Epidermoid carcinoma A431
adherent cells
floating cells
Neuroblastoma IMR 32
adherent cells
floating cells
Neuroblastoma SK-N-SH
adherent cells
floating cells
Breast cancer MCF7
adherent cells
floating cells
Breast cancer MDA 231
adherent cells
floating cells
Human fibroblasts
adherent cells n. d. n. d.
n. d. = not determined
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Fig. 5. Western blot procedure with detergent extracts from
nesidioblastosis pancreas (case 3)
Marker: myosin, Afr200 χ ΙΟ3; -galactosidase, Mr 116
χ IO3; phosphorylase b, Mr 97 χ ΙΟ3; bovine serum
albumin, Mr 66 χ ΙΟ3.
673D2 (Mr 140-150 χ ΙΟ3), 1163Β1 (Mr 97; 125
χ 103)5 794 A2 (MT 97; 150; 200 χ ΙΟ3), while mono-
clonal antibody 866 A6 recognized three distinguished
bands in the range from Mr 40 to 45 χ ΙΟ3.
Discussion
Nesidioblastosis is a rare disease of infants and is
characterized by augmentation of the pancreatic islets
of Langerhans or single islet cells as a result of con-
tinuous formation of new islet cells from the duct
epithelium (7, 8). In most cases the total mass of all
the different cell types of the islets is increased three-
to ten fold. Due to the hyperinsulinism the disease is
clinically characterized by severe hypoglycaemic at-
tacks. Total pancreatectomy is therefore the thera-
peutic method of choice. Jn contrast to solid insulin-
omas, which in most cases secrete insulin autono-
mously, nesidioblastosis tissue remains mostly sensi-
tive to specific stimuli such as glucose, leucine or
others (9). Thus the functional apparatus of the nesi-
dioblastosis islets seems to be relatively intact. Fur-
thermore, diabetic sera reactive with normal islets
were also positive on nesidioblastosis pancreas,
whereas some of the insulinomas we have tested did
not react with diabetic autoantibodies. Therefore nesi-
dioblastosis tissue seems to be the ideal source for
preparation of human islets. The proliferative power
of the isolated nesidioblastosis islets remained de-
monstrable in cell culture up to several months (10).
The tissues (normal pancreas and nesidioblastosis 2)
used in this study for immunofluorescence were from
two donors with blood group 0, thus there was no
interference with the blood group system.
Various immunologic phenomena are usually demon-
strable at onset of type I diabetes, among them the
presence of autoantibodies against cytoplasmic as well
as membrane structures of the B-cells of islets. If the
immune response is in fact responsible for the damage
of the B-cells in type I diabetes, it seems probable
that membrane structures serve as self antigens in
combination with expressed HLA-molecules. We
therefore used the membrane fraction of the nesi-
dioblastosis islet cells as immunogen in BALB/c mice
for induction of specific lymphocytes. Fusion and
selection of the antibody secreting hybrids resulted in
at least 7 clones with different specificity. Antibody
521F2 was only reactive on human pancreas slices,
while most of the others were also positive on bovine
and/or porcine pancreas. Cross-reactivity with differ-
ent cells and tissues from various species seems to be
mainly a function of the screening methods used for
selection of positive clones. As already mentioned by
Garzelli et al. (11), one of the major hurdles in iso-
lating monoclonal islet antibodies is the time and skill
required to screen hundreds of hybrids for reactivity
on tissue slices by immunofluorescence. Since viable
human islet cells are usually not available, most in-
vestigators use the rat insulinoma cell line RIN m 5F
for screening of the respective hybrids (11 —14). This
method selects clones without species specificity and
it seems further that these selected clones are not
specific for islet cells, but react also with other en-
docrine tissues. RIN-cell positive antibodies 303F1,
673D2, D5 and 866A6 reacted also with bovine pan-
creas, a solid neuroblastoma and the neuroblastoma
cell line SK-N-SH. None of the seven clones stained
any structures on human thyroid. Thus it seems clear
that some of our monoclonal antibodies recognize
common epitopes or antigenic determinants on dif-
ferent normal tissues and malignant tumours. This is
in line with reports in the literature about murine
monoclonal islet cell antibodies (15) as well as human
monoclonal antibodies derived from Ebstein-Barr vi-
rus-transformed lymphocytes from diabetics (11, 16).
However at least two of our monoclonal antibodies,
521F2 and 794A2, seem to be islet cell-specific, al-
though the latter stained undefined structures on bo-
vine pancreas.
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All of the antibodies reacting with the neuroblastoma
cell line SK-N-SH gave, rim fluorescence only on
viable adherent cells grown on cover slips. They did
not react with floating cells. A possible explanation
for this discrepancy is the fact that the adherent
growing cells were harvested by mild trypsination, a
procedure, which might have destroyed antigenic pep-
tide structures on the cell surface. This explanation
was confirmed by the Western blot experiments. Pro-
tein antigens were recognized only by those antibodies
reactive with adherent SK-N-SH-cells, but unreactive
with floating cells. Some of our monoclonal antibod-
ies did not recognize proteins using the Western blot
procedure. This fact probably reflected findings on
the carbohydrate or glycolipid nature of specific an-
tigens published by Eisenbarth^ group in a series of
papers (12 — 15). Experiments on the possible non-
peptide nature of the antigens, against which our
monoclonal antibodies are directed, are in progress.
Why 24 of our initial hybrids reacted only in the RIN-
cell ELISA, but not on human cryostat sections re-
mains unclear. These hybrids were excluded from
further cloning.
Up to now there is no clear evidence that monoclonal
antibodies prepared by hybridoma technology or Eb-
stein-Barr-viras transformation recognize the same
structures on human islet cells as do diabetic auto-
antibodies. Nonetheless, islet cell-specific monoclonal
antibodies are providing an approach for identifica-
tion of antigenic determinants common to all endo-
crine cells and those specific for human islet B-cells.
This may help to answer the question, of why type I
diabetes is in fact characterized by a selective destruc-
tion of the B-cells, although the patients have anti-
bodies in their serum against a variety of other en-
docrine organs.
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